A rapid rise in circulating pancreastatin in response to somatostatin analogue therapy is associated with poor survival in patients with neuroendocrine tumours. (Q45977687)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A rapid rise in circulating pancreastatin in response to somatostatin analogue therapy is associated with poor survival in patients with neuroendocrine tumours. |
scientific article |
Statements
1 reference
A rapid rise in circulating pancreastatin in response to somatostatin analogue therapy is associated with poor survival in patients with neuroendocrine tumours. (English)
1 reference
C C Patterson
1 reference
R L Stronge
1 reference
G B Turner
1 reference
B T Johnston
1 reference
D R McCance
1 reference
A McGinty
1 reference
J E S Ardill
1 reference
9 September 2008
1 reference
1 reference
45
1 reference
Pt 6
1 reference
560-566
1 reference
Identifiers
1 reference
1 reference